Global Pediatric Drugs And Vaccines Market Size To Exceed USD 265.5 Billion By 2033 | CAGR of 8.04%
April 17, 2024 15:30 ET
|
SPHERICAL INSIGHTS LLP
New York, United States, April 17, 2024 (GLOBE NEWSWIRE) -- The Global Pediatric Drugs and Vaccines Market Size is to Grow from USD 122.5 Billion in 2023 to USD 265.5 Billion by 2033, at a Compound...
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
April 15, 2024 13:39 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 15 April 2024 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated...
Novo Nordisk A/S - share repurchase programme
April 15, 2024 08:43 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 15 April 2024 – On 6 February 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council...
Anti-obesity Drugs market is estimated to grow at a CAGR of 21.2% by 2034: Visiongain
April 12, 2024 11:17 ET
|
Visiongain Reports Ltd
Visiongain has published a new report entitled Anti-obesity Drugs Market Report 2024-2034: Forecasts by Drug Type (Prescription, OTC), by Mechanism of Action (Glucagon Like Peptide GLP-1 Agonists,...
Novo Nordisk A/S - share repurchase programme
April 08, 2024 09:40 ET
|
Novo Nordisk A/S
Novo Nordisk A/S – Share repurchase programme Bagsværd, Denmark, 08 April 2024 – On 6 February 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No...
Glucagon-Like Peptide 1 (GLP-1) Agonist Market To Reach USD 21.2 Billion By 2032, Report By DataHorizzon Research
April 08, 2024 07:30 ET
|
DataHorizzon Research
Fort Collins, Colorado, April 08, 2024 (GLOBE NEWSWIRE) -- Growing cases of diabetes and obesity trigger the need for GLP-1 receptor agonists Type 2 diabetes and obesity represent critical health...
Novo Nordisk A/S - share repurchase programme
April 02, 2024 06:56 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 2 April 2024 – On 6 February 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council...
Fungicides Market Size is projected to reach USD 23,393.85 million by 2031, growing at a CAGR of 4.6%: Straits Research
March 28, 2024 11:55 ET
|
Straits Research Private Limited - Reed Intelligence
New York, United States, March 28, 2024 (GLOBE NEWSWIRE) -- Modern crop protection against fungal diseases must include fungicides. Due to changes in farming practices and technological...
Hemophilia B Drug Market Size and Share to Grow by 2032, Assesses DelveInsight | Key Emerging Therapies - CSL222, SerpinPC, AskBio009, PF-06838435/fida, Marstacimab, FLT180a, Concizumab, Fitusiran
March 27, 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, March 27, 2024 (GLOBE NEWSWIRE) -- Hemophilia B Drug Market Size and Share to Grow by 2032, Assesses DelveInsight | Key Emerging Therapies - CSL222, SerpinPC, AskBio009,...
Cirrhosis Clinical Trial Pipeline Insights Featuring 45+ Companies | DelveInsight
March 25, 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, March 25, 2024 (GLOBE NEWSWIRE) -- Cirrhosis Clinical Trial Pipeline Insights Featuring 45+ Companies | DelveInsight The rise in the number of people suffering from cirrhosis can be...